Antiviral drug used to treat cats may be effective in treating humans against COVID-19: Research


PTI, Aug 28, 2020, 5:45 PM IST

Image for representation

A drug used to cure a deadly viral disease in cats may be effective as a treatment for humans against the novel coronavirus, according to a study that may lead to the development of new therapeutics to treat COVID-19.

According to the research, published in the journal Nature Communications, the drug is effective at inhibiting viral replication in lab-grown cells infected with the novel coronavirus SARS-CoV-2.

“This drug is very likely to work in humans, so we’re encouraged that it will be an effective antiviral treatment for COVID-19 patients,” said Joanne Lemieux, a professor of biochemistry at the University of Alberta.

The scientists noted that the drug interferes with the virus’s ability to replicate, and may help end the infection.

They said the drug is an inhibitor of some of the body’s protease molecules, which are key to many body functions, and are common targets for drugs to treat “everything from high blood pressure to cancer and HIV.”

According to the scientists, the drug was first studied following the 2002-03 SARS pandemic, following which the protease inhibitor was further developed by veterinary researchers who showed it cures a disease that is fatal in cats.

“We determined the three-dimensional shape of the protease with the drug in the active site pocket, showing the mechanism of inhibition. This will allow us to develop even more effective drugs,” Lemieux said.

The scientists said they plan to test modifications of the drug to make it an even better fit inside the virus.

But, according to Lemieux, the current drug shows enough antiviral action against SARS-CoV-2 to proceed immediately to clinical trials.

“Typically for a drug to go into clinical trials, it has to be confirmed in the lab and then tested in animal models,” Lemieux said.

“Because this drug has already been used to treat cats with coronavirus, and it’s effective with little to no toxicity, it’s already passed those stages and this allows us to move forward,” she added.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Aircraft carrier Vikrant completes third sea trials, returns to Kochi harbour

Bihar ruling allies BJP, JD(U) spar over Emperor Asoka controversy

Clarify stand on marital rape criminalisation: Delhi HC tells Centre

Udupi Paryaya to be held without fanfare

Petrol, diesel sales fall in Jan as Omicron spreads

Mysuru: Six arrested for thrashing Dalit family for eating ‘panipuri’

JK admin takes back Kashmir Press Club premises, says it has ‘ceased to exist’


Related Articles More

Experts foresee COVID peak on Jan 25 in Karnataka: Minister R Ashoka

34,047 Covid-19 cases, 13 deaths reported in Karnataka

Kerala clocks 18,123 new coronavirus cases

One year on, vaccines still most acceptable weapon against COVID-19

Tech in Covid battle: Karnataka model to entire country, says Sudhakar

MUST WATCH

Night Curfew : Shops, stall will close before 10pm(jan 17)

NEWS BULLETIN 17-01-2022

THE HISTORY OF KRISHNAPURA MUTT SWAMIJI

DOCTOR BEATS UP A VEGETABLE VENDOR

Vidyasagara Teertha Swamiji Paryaya Message


Latest Additions

Aircraft carrier Vikrant completes third sea trials, returns to Kochi harbour

Bihar ruling allies BJP, JD(U) spar over Emperor Asoka controversy

Clarify stand on marital rape criminalisation: Delhi HC tells Centre

Udupi Paryaya to be held without fanfare

Petrol, diesel sales fall in Jan as Omicron spreads

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.